Phosphorus–nitrogen compounds part 33: in vitro cytotoxic and antimicrobial activities, DNA interactions, syntheses, and structural investigations of new mono(4-nitrobenzyl)spirocyclotriphosphazenes
详细信息    查看全文
  • 作者:Aytuğ Okumuş ; Hüseyin Akbaş ; Zeynel Kılıç…
  • 关键词:Spirocyclotriphosphazenes ; Spectroscopy ; Crystal structure ; Cytotoxicity ; Breast and HeLa cancer cell lines ; DNA interactions
  • 刊名:Research on Chemical Intermediates
  • 出版年:2016
  • 出版时间:May 2016
  • 年:2016
  • 卷:42
  • 期:5
  • 页码:4221-4251
  • 全文大小:1,701 KB
  • 参考文献:1.A. Uslu, S. Yeşilot, Coord. Chem. Rev. 291, 28 (2015)CrossRef
    2.V. Chandrasekhar, P. Thilagar, B.M. Pandian, Coord. Chem. Rev. 251(9–10), 1045 (2007)CrossRef
    3.C.W. Allen, Chem. Rev. 91(2), 119 (1991)CrossRef
    4.K. Koran, F. Özen, G. Torğut, G. Pıhtılı, E. Çil, A.O. Görgülü, M. Arslan, Polyhedron 79, 213 (2014)CrossRef
    5.N. Asmafiliz, Z. Kılıç, Z. Hayvalı, L. Açık, T. Hökelek, H. Dal, Y. Öner, Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 86, 214 (2012)CrossRef
    6.S. Bilge, A. Natsagdorj, Ş. Demiriz, N. Caylak, Z. Kılıç, T. Hökelek, Helv. Chim. Acta 87(8), 2088 (2004)CrossRef
    7.S. Bilge, Ş. Demiriz, A. Okumuş, Z. Kılıç, B. Tercan, T. Hökelek, O. Büyükgüngör, Inorg. Chem. 45(21), 8755 (2006)CrossRef
    8.M. Işıklan, N. Asmafiliz, E.E. Özalp, E.E. İlter, Z. Kılıç, B. Çoşut, S. Yeşilot, A. Kılıç, A. Öztürk, T. Hökelek, L.Y. Koç, L. Açık, E. Akyüz, Inorg. Chem. 49(15), 7057 (2010)CrossRef
    9.M. Gleria, R.D. Jaeger, Nova Science Publishers Inc (Hauppauge, New York, 2004)
    10.E. Okutan, B. Çoşut, S.B. Kayıran, M. Durmuş, A. Kılıç, S. Yeşilot, Polyhedron 67, 344 (2014)CrossRef
    11.Ş.Ş. Ün, Polyhedron 70, 148 (2014)CrossRef
    12.B. Çoşut, H. İbişoğlu, A. Kılıç, S. Yeşilot, Inorg. Chim. Acta 362(14), 4931 (2009)CrossRef
    13.P.G. Avaji, H.I. Joo, J.H. Park, K.S. Park, Y.J. Jun, H.J. Lee, Y.S. Sohn, J. Inorg. Biochem. 140, 45 (2014)CrossRef
    14.S.S. Machakanur, B.R. Patil, G.N. Naik, R.P. Bakale, S.W.A. Bligh, K.B. Gudasi, Inorg. Chim. Acta 421, 459 (2014)CrossRef
    15.I. Porwolik-Czomperlik, M. Siwy, D. Sek, B. Kaczmarczyk, A. Nasulewicz, I. Jaroszewicz, M. Pelczynska, A. Opolski, Acta Pol. Pharm. 61(4), 267 (2004)
    16.K. Brandt, T.J. Bartczak, R. Kruszynski, I. Porwolik-Czomperlik, Inorg. Chim. Acta 322(1–2), 138 (2001)CrossRef
    17.J.L. Sassus, M. Graffeuil, P. Castera, J.F. Labarre, Inorg. Chim. Acta 108(1), 23 (1985)CrossRef
    18.T. Yıldırım, K. Bilgin, G. Yenilmez Çiftçi, E. Tanrıverdi Eçik, E. Şenkuytu, Y. Uludağ, L. Tomak, A. Kılıç, Eur. J. Med. Chem. 52, 213 (2012)CrossRef
    19.Z. Kılıç, A. Okumuş, Ş. Demiriz, S. Bilge, A. Öztürk, T. Hökelek, J. Incl. Phenom. Macrocycl. Chem. 65(3–4), 269 (2009)
    20.A. Okumuş, S. Bilge, Z. Kılıç, A. Öztürk, T. Hökelek, F. Yılmaz, Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 76(3–4), 401 (2010)CrossRef
    21.Y. Tümer, N. Asmafiliz, Z. Kılıç, T. Hökelek, L.Y. Koç, L. Açık, M.L. Yola, A.O. Solak, Y. Öner, D. Dündar, M. Yavuz, J. Mol. Struct. 1049, 112 (2013)CrossRef
    22.N. Asmafiliz, Z. Kılıç, A. Öztürk, Y. Süzen, T. Hökelek, L. Açık, Z.B. Çelik, L.Y. Koç, M.L. Yola, Z. Üstündağ, Phosphorus Sulfur Silicon Relat. Elem. 188(12), 1723 (2013)CrossRef
    23.H. Akbaş, A. Okumuş, Z. Kılıç, T. Hökelek, Y. Süzen, L.Y. Koç, L. Açık, Z.B. Çelik, Eur. J. Med. Chem. 70, 294 (2013)CrossRef
    24.Bruker Program 1D WIN-NMR (release 6.0) and 2D WIN-NMR (release 6.1)
    25.G. Elmas, A. Okumuş, L.Y. Koç, H. Soltanzade, Z. Kılıç, T. Hökelek, H. Dal, L. Açık, Z. Üstündağ, D. Dündar, M. Yavuz, Eur. J. Med. Chem. 87, 662 (2014)CrossRef
    26.Bruker, SADABS (Bruker AXS Inc, Madison, Wisconsin, 2005)
    27.G.M. Sheldrick, SHELXS-97; SHELXL-97 (University of Göttingen, Göttingen, Germany, 1997)
    28.G.M. Sheldrick, Acta Crystallogr. Sect. A. 64, 112 (2008)CrossRef
    29.L.J. Farrugia, J. Appl. Cryst. 45, 849 (2012)CrossRef
    30.T. Mossmann, J. Immunol. Methods 65(1–2), 55 (1983)CrossRef
    31.Z.M.O. Rzayev, M. Tűrk, E.A. Söylemez, Bioorg. Med. Chem. 20(16), 5053 (2012)CrossRef
    32.M. Türk, Z.M.O. Rzayev, S.A. Khalilova, Bioorg. Med. Chem. 18(22), 7975 (2010)CrossRef
    33.Clinical and Laboratory Standards Institute, in Performance Standards for Antimicrobia Susceptibility Testing Sixteenth Informational Supplement. CLSI document M100eS16, Pennsylvania, (2006)
    34.Y. Tümer, L.Y. Koç, N. Asmafiliz, Z. Kılıç, T. Hökelek, H. Soltanzade, L. Açık, M.L. Yola, A.O. Solak, J. Biol. Inorg. Chem. 20(1), 165 (2015)CrossRef
    35.L. Lázár, A. Göblyös, F. Evanics, G. Bernáth, F. Fülöp, Tetrahedron 54(44), 13639 (1998)CrossRef
    36.A. Okumuş, Z. Kılıç, T. Hökelek, H. Dal, L. Açık, Y. Öner, L.Y. Koç, Polyhedron 30(17), 2896 (2011)CrossRef
    37.V. Vicente, A. Fruchier, H.J. Cristau, Magn. Reson. Chem. 41(3), 183 (2003)CrossRef
    38.G.A. Carriedo, F.G. Alonso, P.A. Gonzalez, J.R. Menendez, J. Raman Spectrosc. 29(4), 327 (1998)CrossRef
    39.D. Cremer, J.A. Pople, J. Am. Chem. Soc. 97(6), 1354 (1975)CrossRef
    40.G.J. Bullen, J. Chem. Soc. A. 1450 (1971)
    41.B. Tercan, T. Hökelek, O. Büyükgüngör, S. Bilge, A. Okumuş, Z. Kılıç, Anal. Sci. 23, 121 (2007)CrossRef
    42.A. Kılıç, S. Begeç, B. Çetinkaya, T. Hökelek, Z. Kılıç, N. Gündüz, M. Yıldız, Heteroat. Chem. 7(4), 249 (1996)CrossRef
    43.F.H. Allen, O. Kennard, D.G. Watson, L. Brammer, G. Orpen, R.J. Taylor, J. Chem. Soc. Perkin Trans. 2, 1 (1987)CrossRef
    44.J.K. Fincham, H.G. Parkes, L.S. Shaw, R.A. Shaw, M.B. Hursthouse, J. Chem. Soc. Dalton Trans. 1169 (1988)
    45.V.L. Minkin, R.M. Minyaev, Chem. Rev. 101(5), 1247 (2001)CrossRef
    46.A.B. Chaplin, J.A. Harrison, P.J. Dyson, Inorg. Chem. 44(23), 8407 (2005)CrossRef
    47.R.J. Davidson, E.W. Ainscough, A.M. Brodie, J.A. Harrison, M.R. Waterland, Eur. J. Inorg. Chem. 11, 1619 (2010)CrossRef
    48.S. Patel, N. Gheewala, A. Suthar, A. Shah, Int. J. Pharm. Pharm. Sci. 1(1), 38 (2009)
    49.G. Elmas, A. Okumuş, Z. Kılıç, T. Hökelek, L. Açık, H. Dal, N. Ramazanoğlu, L.Y. Koç, Inorg. Chem. 51(23), 12841 (2012)CrossRef
  • 作者单位:Aytuğ Okumuş (1)
    Hüseyin Akbaş (2)
    Zeynel Kılıç (1)
    L. Yasemin Koç (3)
    Leyla Açık (4)
    Betül Aydın (4)
    Mustafa Türk (5)
    Tuncer Hökelek (6)
    Hakan Dal (7)

    1. Department of Chemistry, Ankara University, 06100, Ankara, Turkey
    2. Department of Chemistry, Gaziosmanpaşa University, 60150, Tokat, Turkey
    3. The Turkish Sugar Authority, 06510, Ankara, Turkey
    4. Department of Biology, Gazi University, 06500, Ankara, Turkey
    5. Department of Bioengineering, Kırıkkale University, Kirikkale, Turkey
    6. Department of Physics, Hacettepe University, 06800, Ankara, Turkey
    7. Department of Chemistry, Anadolu University, 26470, Eskisehir, Turkey
  • 刊物类别:Chemistry and Materials Science
  • 刊物主题:Chemistry
    Catalysis
    Physical Chemistry
    Inorganic Chemistry
  • 出版者:Springer Netherlands
  • ISSN:1568-5675
文摘
The condensation reactions of hexachlorocyclotriphosphazene, N3P3Cl6, with N-alkyl-N′-mono(4-nitrobenzyl)diamines (1–3), NO2PhCH2NH(CH2) n NHR1 (R1 = CH3 or C2H5), led to the formation of the mono(4-nitrobenzyl)spirocyclotriphosphazenes (4–6). The tetra-pyrrolidino (4a–6a), piperidino (4b–6b), and 1,4-dioxa-8-azaspiro[4,5]decaphosphazenes (4c–6c) were prepared from(for) the reactions of partly substituted compounds (4, 5, and 6) with excess pyrrolidine, piperidine, and 1,4-dioxa-8-azaspiro[4,5]decane (DASD), respectively. The partly substituted geminal (4d and 5d) and cis-morpholino (6d) phosphazenes were isolated from the reactions of excess morpholine in boiling THF and o-xylene, but the expected fully substituted compounds were not obtained. The structures of all the phosphazene derivatives were determined by elemental analyses, MS, FTIR, 1H, 13C{1H}, 31P{1H} NMR, HSQC, and HMBC techniques. The crystal structures of 4, 6, 4a, and 5a were verified by X-ray diffraction analysis. In addition, in vitro cytotoxic activities of fully substituted phosphazenes (4a–6c) against HeLa cervical cancer cell lines (ATCC CCL-2) and the compounds 4a and 4c against breast cancer cell lines (MDA-MB-231) and L929 fibroblast cells were evaluated, respectively. Apoptosis effect was determined by MDA-MB-231 cancer cell lines and fibroblast cells. The MIC values of the compounds were in the ranges of 9.8–19.5 µM. The compounds 6, 5a, 6a, 5b, and 6d have greater MIC activity against bacterial and yeast strain. The investigation of DNA binding with the phosphazenes was studied using plasmid DNA. The phosphazene derivatives inhibit the restriction endonuclease cleavage of plasmid DNA by BamHI and HindIII enzymes. BamHI and HindIII digestion results demonstrate that the compounds bind with G/G and A/A nucleotides.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700